GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » GenMark Diagnostics Inc (NAS:GNMK) » Definitions » Inventory Turnover

GenMark Diagnostics (GenMark Diagnostics) Inventory Turnover : 1.50 (As of Dec. 2020)


View and export this data going back to 2010. Start your Free Trial

What is GenMark Diagnostics Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. GenMark Diagnostics's Cost of Goods Sold for the three months ended in Dec. 2020 was $30.7 Mil. GenMark Diagnostics's Average Total Inventories for the quarter that ended in Dec. 2020 was $20.4 Mil. GenMark Diagnostics's Inventory Turnover for the quarter that ended in Dec. 2020 was 1.50.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. GenMark Diagnostics's Days Inventory for the three months ended in Dec. 2020 was 60.81.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. GenMark Diagnostics's Inventory-to-Revenue for the quarter that ended in Dec. 2020 was 0.41.

GenMark Diagnostics Inventory Turnover Historical Data

The historical data trend for GenMark Diagnostics's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GenMark Diagnostics Inventory Turnover Chart

GenMark Diagnostics Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.07 3.70 4.84 5.52 6.35

GenMark Diagnostics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.51 2.13 1.95 1.51 1.50

GenMark Diagnostics Inventory Turnover Calculation

GenMark Diagnostics's Inventory Turnover for the fiscal year that ended in Dec. 2020 is calculated as

Inventory Turnover (A: Dec. 2020 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2020 ) / ((Total Inventories (A: Dec. 2019 ) + Total Inventories (A: Dec. 2020 )) / count )
=103.61 / ((11.301 + 21.323) / 2 )
=103.61 / 16.312
=6.35

GenMark Diagnostics's Inventory Turnover for the quarter that ended in Dec. 2020 is calculated as

Inventory Turnover (Q: Dec. 2020 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Dec. 2020 ) / ((Total Inventories (Q: Sep. 2020 ) + Total Inventories (Q: Dec. 2020 )) / count )
=30.682 / ((19.57 + 21.323) / 2 )
=30.682 / 20.4465
=1.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GenMark Diagnostics  (NAS:GNMK) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

GenMark Diagnostics's Days Inventory for the three months ended in Dec. 2020 is calculated as:

Days Inventory =Average Total Inventories (Q: Dec. 2020 )/Cost of Goods Sold (Q: Dec. 2020 )*Days in Period
=20.4465/30.682*365 / 4
=60.81

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

GenMark Diagnostics's Inventory to Revenue for the quarter that ended in Dec. 2020 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2020 ) / Revenue (Q: Dec. 2020 )
=20.4465 / 50.08
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

GenMark Diagnostics Inventory Turnover Related Terms

Thank you for viewing the detailed overview of GenMark Diagnostics's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

GenMark Diagnostics (GenMark Diagnostics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » GenMark Diagnostics Inc (NAS:GNMK) » Definitions » Inventory Turnover
Comparable Companies
ZYXI VREX OFIX NTUS QTRX VAPO INGN KIDS CRY SIBN ABT MDT SYK BSX SZSE:300760 EW ZBH ALGN LSE:SN. BIO
Traded in Other Exchanges
N/A
Address
5964 La Place Court, Carlsbad, CA, USA, 92008-8829
Website
http://www.genmarkdx.com
GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its operations and assets are in the United States of America.
Executives
Tyler Jensen officer: SVP, Engineering and Tech Dev 5964 LA PLACE COURT CARLSBAD CA 92008
Christine Shaw officer: VP, Assay Development 5964 LA PLACE COURT CARLSBAD CA 92008
Alan Baer Maderazo officer: VP, Qual, Reg, & Clin Affairs 5964 LA PLACE COURT CARLSBAD CA 92008
Michael Gleeson officer: SVP, Corp. Accounts 5964 LA PLACE COURT, SUITE 100 CARLSBAD CA 92008
Sarah Hollis Winkler officer: VP, Human Resources 5964 LA PLACE COURT CARLSBAD CA 92008
Michael John Harkins officer: SVP, Sales 5964 LA PLACE COURT CARLSBAD CA 92008
John Frederick Ek officer: Chief Financial Officer 5964 LA PLACE COURT, CARLSBAD CA 92008
Scott Mendel director, officer: President & CEO 5964 LA PLACE COURT, ADDRESS 2, CARLSBAD CA 92008
Eric Stier officer: SVP & General Counsel 5964 LA PLACE COURT CARLSBAD CA 92008
Brian Andrew Mitchell officer: SVP, Operations 5964 LA PLACE COURT CARLSBAD CA 92008
Daryl Faulkner director 5964 LA PLACE COURT, CARLSBAD CA 92008
Michael Kagnoff director DLA PIPER LLP (US) 4365 EXECUTIVE DRIVE, SUITE 1100 SAN DIEGO CA 92121
Lisa M. Giles director DURATA THERAPEUTICS, INC., 200 SOUTH WACKER DRIVE SUITE 2550, CHICAGO IL 60606
Kevin C Oboyle director 5964 LA PLACE COURT, CARLSBAD CA 92008
James Fox director 5964 LA PLACE COURT, CARLSBAD CA 92008